PAR PHARMACEUTICAL COMPANIES, INC. Future Amortization Expense, after Year Five (Deprecated 2012-01-31)
PAR PHARMACEUTICAL COMPANIES, INC. reported Future Amortization Expense, after Year Five (Deprecated 2012-01-31) of $107.91 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseAfterYearFive · last filed 2012-08-02
- PAR PHARMACEUTICAL COMPANIES, INC. future amortization expense, after year five (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $136.37M.
- PAR PHARMACEUTICAL COMPANIES, INC. future amortization expense, after year five (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $1.00K.
- PAR PHARMACEUTICAL COMPANIES, INC. future amortization expense, after year five (deprecated 2012-01-31) for fiscal 2011 was $175.55M.
| Period end | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 0 month | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 3 month | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 6 month | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 9 month | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|---|
| 2012-06-30 | $107.91M 10-Q · filed 2012-08-02 | ||||
| 2012-03-31 | $105.07M 10-Q · filed 2012-05-08 | ||||
| 2011-12-31 | $136.37M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $136.37M derived: sum of 2 quarters · filed 2012-02-28 | $175.55M 10-K · filed 2012-02-28 | ||
| 2011-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $39.18M 10-Q · filed 2011-11-02 | |||
| 2011-06-30 | $39.17M 10-Q · filed 2011-08-03 |